スピロテトラマトの世界市場

世界のスピロテトラマトの市場規模は、分析期間（2020年～2027年）に4.3％のCAGRで成長する見通しで、2020年の1億9,630万米ドルから、2027年には2億6,340万米ドルに達すると予測されています。

当レポートは、世界のスピロテトラマト市場について調査しており、市場シェア、Covid-19の影響、動向や成長要因、地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

調査対象企業の例

• Bayer CropScience

目次

I. 調査手法

II. エグゼクティブサマリー

• 市場概要
  • インフルエンサー市場の洞察
  • 世界市場の軌跡
  • Covid-19の影響と迫り来る世界の景気後退
• 主要企業
• 動向と推進要因
• 世界市場の見通し

III. 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

IV. 競合

• 企業プロファイル：46社

Abstract:

Global Spirotetramat Market to Reach $263.4 Million by 2027

Amid the COVID-19 crisis, the global market for Spirotetramat estimated at US$196.3 Million in the year 2020, is projected to reach a revised size of US$263.4 Million by 2027, growing at a CAGR of 4.3% over the period 2020-2027.

The U.S. Market is Estimated at $53 Million, While China is Forecast to Grow at 6.9% CAGR

The Spirotetramat market in the U.S. is estimated at US$53 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$54 Million by the year 2027 trailing a CAGR of 6.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.5% and 3.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.

Select Competitors (Total 46 Featured) -

• Bayer CropScience

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Current & Future Analysis for Spirotetramat by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • TABLE 2: World Historic Review for Spirotetramat by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 3: World 15-Year Perspective for Spirotetramat by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

• UNITED STATES
  • TABLE 4: USA Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 5: USA Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
• CANADA
  • TABLE 6: Canada Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 7: Canada Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
• JAPAN
  • TABLE 8: Japan Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 9: Japan Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
• CHINA
  • TABLE 10: China Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 11: China Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
• EUROPE
  • TABLE 12: Europe Current & Future Analysis for Spirotetramat by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • TABLE 13: Europe Historic Review for Spirotetramat by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 14: Europe 15-Year Perspective for Spirotetramat by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
• FRANCE
  • TABLE 15: France Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 16: France Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
• GERMANY
  • TABLE 17: Germany Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 18: Germany Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
• ITALY
  • TABLE 19: Italy Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 20: Italy Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
• UNITED KINGDOM
  • TABLE 21: UK Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 22: UK Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
• SPAIN
  • TABLE 23: Spain Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 24: Spain Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
• RUSSIA
  • TABLE 25: Russia Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 26: Russia Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
• REST OF EUROPE
  • TABLE 27: Rest of Europe Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 28: Rest of Europe Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
• ASIA-PACIFIC
  • TABLE 29: Asia-Pacific Current & Future Analysis for Spirotetramat by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • TABLE 30: Asia-Pacific Historic Review for Spirotetramat by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 31: Asia-Pacific 15-Year Perspective for Spirotetramat by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
• AUSTRALIA
  • TABLE 32: Australia Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 33: Australia Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
• INDIA
  • TABLE 34: India Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 35: India Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
• SOUTH KOREA
  • TABLE 36: South Korea Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 37: South Korea Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
• REST OF ASIA-PACIFIC
  • TABLE 38: Rest of Asia-Pacific Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 39: Rest of Asia-Pacific Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
• LATIN AMERICA
  • TABLE 40: Latin America Current & Future Analysis for Spirotetramat by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • TABLE 41: Latin America Historic Review for Spirotetramat by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 42: Latin America 15-Year Perspective for Spirotetramat by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
• ARGENTINA
  • TABLE 43: Argentina Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 44: Argentina Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
• BRAZIL
  • TABLE 45: Brazil Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 46: Brazil Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
• MEXICO
  • TABLE 47: Mexico Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 48: Mexico Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
• REST OF LATIN AMERICA
  • TABLE 49: Rest of Latin America Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 50: Rest of Latin America Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
• MIDDLE EAST
  • TABLE 51: Middle East Current & Future Analysis for Spirotetramat by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • TABLE 52: Middle East Historic Review for Spirotetramat by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 53: Middle East 15-Year Perspective for Spirotetramat by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
• IRAN
  • TABLE 54: Iran Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 55: Iran Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
• ISRAEL
  • TABLE 56: Israel Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 57: Israel Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
• SAUDI ARABIA
  • TABLE 58: Saudi Arabia Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 59: Saudi Arabia Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
• UNITED ARAB EMIRATES
  • TABLE 60: UAE Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 61: UAE Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
• REST OF MIDDLE EAST
  • TABLE 62: Rest of Middle East Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 63: Rest of Middle East Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
• AFRICA
  • TABLE 64: Africa Current & Future Analysis for Spirotetramat by Segment - Spirotetramat - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 65: Africa Historic Review for Spirotetramat by Segment - Spirotetramat Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR

IV. COMPETITION

• Total Companies Profiled: 46